The store will not work correctly when cookies are disabled.
ID: ALA4173369
Max Phase: Preclinical
Molecular Formula: C19H15N7
Molecular Weight: 341.38
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1ncc(C)n2nc(-c3ccn4cc(-c5ccccc5)nc4n3)nc12
Standard InChI: InChI=1S/C19H15N7/c1-12-10-20-13(2)18-23-17(24-26(12)18)15-8-9-25-11-16(22-19(25)21-15)14-6-4-3-5-7-14/h3-11H,1-2H3
Standard InChI Key: VODQJEUBIZNJSP-UHFFFAOYSA-N
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 341.38 | Molecular Weight (Monoisotopic): 341.1389 | AlogP: 3.12 | #Rotatable Bonds: 2 |
| Polar Surface Area: 73.27 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 2.15 | CX LogP: 3.27 | CX LogD: 3.27 |
| Aromatic Rings: 5 | Heavy Atoms: 26 | QED Weighted: 0.49 | Np Likeness Score: -1.81 |
References
| 1. Moszczyński-Pętkowski R, Majer J, Borkowska M, Bojarski Ł, Janowska S, Matłoka M, Stefaniak F, Smuga D, Bazydło K, Dubiel K, Wieczorek M.. (2018) Synthesis and characterization of novel classes of PDE10A inhibitors - 1H-1,3-benzodiazoles and imidazo[1,2-a]pyrimidines., 155 [PMID:29870883] [10.1016/j.ejmech.2018.05.043] |
